Table 2 Oncological and surgical outcome
bottom-to-up (BTU-group) | medial-to-lateral (MLT-group) | p-value | |
|---|---|---|---|
n = 17 | n = 7 | ||
T-stage (%(n)) | |||
1 | 11,8 (2) | 14.3 (1) | 0.153 (F) |
2 | 11,8 (2) | 28,6 (2) | |
3 | 70,6 (12) | 28,6 (2) | |
4 | 5,9 (1) | 28,6 (2) | |
N-Stage (%(n)) | |||
0 | 58,8 (10) | 85,7 (6) | 0.332 (F) |
1 | 29,4 (5) | 0.0 (0) | |
2 | 11,8 (2) | 14,3 (1) | |
Tumor involved margins (%(n)) | 0 (0) | 0 (0) | 1 |
Total no. retrieved lymph nodes | |||
mean ± SD | 40.2 ± 17.1 | 16.3 ± 8.5 | < 0.001 (W) |
median (range) | 38 (14–86) | 12 (9–30) | |
Cases with fewer than 12 LNs (%(n)) | 0.0 (0) | 28.6 (2) | 0.045 (F) |
No. of positive lymph nodes, median (range) | 0 (0–15) | 0 (0–5) | 0.272 (W) |
n = 24 | N = 7 | ||
No. of conversions | 0 (0) | 0 (0) | 1.000 (F) |
Skin-to-skin OR-time (min; mean ± SD) | 283.6 ± 87.9 | 287.5 ± 45.0 | 0.671 (W) |
time to first flatus (d; mean ± SD) | 1.4 ± 1.1 | 0.6 ± 1.0 | 0.074 (W) |
ICU stay (d; median (range)) | 0.0 (0–8) | 0.0 (0–1) | 0.534 (W) |
Hospital stay (d; mean ± SD)) | 10.7 ± 2.6 | 11.6 ± 3.7 | 0.721 (W) |
Patients with complications (%(n)) | 33.3 (8) | 42.9 (3) | 0.676 (F) |
Patients with DinCla complications (%(n)) | |||
DinCla I complications | 29.2 (7) | 28.6 (2) | 0.633 (F) |
DinCla II complications | 4.2 (1) | 14.3 (1) | |
DinCla III/IV complications | 0.0 (0) | 0.0 (0) | |
Postoperative mortality / DinCla V (%(n)) | 0.0 (0) | 0.0 (0) | 1.000 (F) |
Type of morbidity (%(n)) | |||
Surgical site infection | 8.3 (2) | 0.0 (0) | 1.000 (F) |
Ileus | 0.0 (0) | 0.0 (0) | 1.000 (F) |
Anastomotic leakage | 0.0 (0) | 0.0 (0) | 1.000 (F) |
anemia | 4.4 (1) | 14.3 (1) | 0.406 (F) |
Pneumonia | 12.5 (3) | 0.0 (0) | 1.000 (F) |
urinary tract infection | 4.4 (1) | 0.0 (0) | 1.000 (F) |
lymphatic fistula | 4.4 (1) | 0.0 (0) | 1.000 (F) |
incisional hernia | 4.4 (1) | 14.3 (1) | 0.406 (F) |